| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Ernexa Therapeutics Inc.
13G/A
ERNA · 114082407
|
7.0% |
10/30/2026
Event 8/5/2026
|
||||
| Freebird Partners LP | 7.0% | |||||
| Freebird Investments LLC | 7.0% | |||||
| Curtis Huff | 7.0% | |||||
|
Ernexa Therapeutics Inc.
13G/A
ERNA · 114082308
|
9.9% |
12/19/2025
Event 12/19/2025
|
||||
| Freebird Partners LP | 9.9% | |||||
| Freebird Investments LLC | 9.9% | |||||
| Curtis Huff | 9.9% | |||||
|
Ernexa Therapeutics Inc.
13G/A
ERNA · 114082209
|
9.9% |
5/14/2025
Event 3/31/2025
|
||||
| Freebird Partners LP | 9.9% | |||||
| Freebird Investments LLC | 9.9% | |||||
| Curtis Huff | 9.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.